These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10921255)

  • 1. [The effect of alpha-1 adrenergic blockade on the clinical course, immune status and blood plasma lipid spectrum in patients with ischemic heart disease].
    Lizogub VG; Chumak AA; Savchenko AV; Pliskevich DA
    Lik Sprava; 2000; (3-4):31-4. PubMed ID: 10921255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamics of immunologic indices in patients with ischemic heart disease on a course of doxazosin therapy].
    Lyzohub VH; Savchenko OV; Chumak AA; Dykukha IS
    Lik Sprava; 2003; (5-6):85-9. PubMed ID: 14618814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of thymalin on lipid metabolism and the clinical course of ischemic heart disease].
    Shustval' NF
    Lik Sprava; 1992 Sep; (9):73-6. PubMed ID: 1481512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The efficacy of proxodolol, a new beta-adrenoblockader with alpha-adrenoblockader properties, in its single use in patients with stable stenocardia of effort].
    Metelitsa VI; Martsevich SIu; Kozyreva MP; Slastnikova ID; Vakulovskaia MK
    Eksp Klin Farmakol; 1994; 57(3):47-50. PubMed ID: 7914121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinico-immunological disorders in patients with ischemic heart disease combined with metabolic syndrome and modulating effect of nebivolol for their correction].
    Tepliakov AT; Bolotskaia LA; Vdovina TV; Stepacheva TA; Kuznetsova AV
    Ter Arkh; 2008; 80(12):44-52. PubMed ID: 19227907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of the new cardioprotective agent thiotriazoline in the therapy of ischemic heart disease in older patients].
    Dunaev VV; Kraĭdashenko OV; Berezin AE
    Eksp Klin Farmakol; 1996; 59(1):21-3. PubMed ID: 8704625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Agents for the metabolic correction of myocardial energy metabolism in treating patients with ischemic heart disease].
    Vizyr AD; Kraĭdashenko OV; Berezin OIe; Oliĭnyk OI
    Lik Sprava; 2000 Mar; (2):26-30. PubMed ID: 10862469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of tactivin for treating patients with IHD].
    Klimov AN; Almazov VA; Nagornev VA; Denisenko AD; Pigarevskiĭ PV; Ogurtsov RP; Sergeeva EG; Sitnikova OD; Popov VG
    Ter Arkh; 1995; 67(9):24-7. PubMed ID: 7495034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of long-term administration of propranolol to patients with ischemic heart disease].
    Bychko MV
    Lik Sprava; 2003; (5-6):93-5. PubMed ID: 14618816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The correlations of lipid peroxidation, antioxidant protection and microrheological disorders in the development of IHD].
    Zakirova AN
    Ter Arkh; 1996; 68(9):37-40. PubMed ID: 9005610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pharmacodynamics of proxodolol when administered once and in a course of doses to patients with stenocardia of effort].
    Petrov IN; Rumiantsev AS; Smirnov MV
    Eksp Klin Farmakol; 1994; 57(3):54-7. PubMed ID: 7914123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of antidepressants on lipid metabolism and the clinical course in IHD].
    Vinokur VA; Gubachev IuM
    Ter Arkh; 1994; 66(11):76-80. PubMed ID: 7900028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of histochrome on the lipid peroxidation indices during the surgical treatment of patients with ischemic heart disease of different functional classes].
    Afanas'ev SA; Lasukova TV; Cherniavskiĭ AM; Vecherskiĭ IuIu; Ponomarenko IV
    Eksp Klin Farmakol; 1999; 62(6):32-4. PubMed ID: 10650524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An amino acid metabolic complex in optimizing the cardiac hemodynamic characteristics of patients with ischemic heart disease].
    Berezin AE; Fushteĭ IM; Kraĭdashenko OV
    Lik Sprava; 1998 Dec; (8):94-6. PubMed ID: 10204359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of quantum therapy for the treatment of stable angina].
    Novyts'kyĭ OV
    Lik Sprava; 2001; (5-6):111-4. PubMed ID: 11881342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-adrenergic blockade in vasotonic angina: lack of efficacy of specific alpha 1-receptor blockade with prazosin.
    Robertson RM; Bernard YD; Carr RK; Robertson D
    J Am Coll Cardiol; 1983 Dec; 2(6):1146-50. PubMed ID: 6138377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of diltiazem on neurohumoral regulatory mechanisms in stenocardia patients].
    Kniaz'kova II; Belovol AN; Tsygankov AI
    Lik Sprava; 1998 Aug; (6):86-90. PubMed ID: 9844884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The optimization of the hemodynamic characteristics in patients with ischemic heart disease and circulatory failure by using a substrate-coenzyme complex].
    Vizir AD; Dunaev VV; Berezin AE; Kraĭdashenko OV
    Lik Sprava; 1997; (5):53-6. PubMed ID: 9491697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of the antioxidant coenzyme Q10 as a cytoprotection variant in ischemic heart disease].
    Syrkin AL; Kogan AKh; Drinitsina SV; Kuznetsov AB; Pechorina EA; Frenkel' EE; Kuleshova NN; Golovnia LD
    Klin Med (Mosk); 1998; 76(7):24-8. PubMed ID: 9742773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.